20 06, 2017

Opioid dependent babies benefit from buprenorphine when suffering from neonatal abstinence syndrome

June 20th, 2017|Categories: Opiates|Tags: , , , , , , , , |0 Comments

Newborns suffering from neonatal abstinence syndrome do better when treated with sublingual buprenorphine than the usual oral morphine, says new study There’s been a lot of attention on the so-called “opioid epidemic” in America recently, and media coverage regularly echoes the call for wider application of medication assisted treatment (MAT), especially buprenorphine, which helps reduce opioid withdrawal symptoms while coming off heroin or opioid painkillers, for example. Stepping down the daily dose of buprenorphine, which is used routinely at Novus for this purpose, results in a faster and more comfortable withdrawal from opioid dependence. Buprenorphine is also helpful when used as a “holding” drug for [...]

13 06, 2017

Prescribing more opioids than needed can be dangerous

June 13th, 2017|Categories: Opiates|Tags: , , , |0 Comments

A recent study at Johns Hopkins Hospital in Baltimore, MD, has found that most orthopedic surgery patients go home with far more opioid pain pills than they need – some times as many as 80 pills too many. And it’s not uncommon for other types of patients to be overprescribed. So what’s wrong with having some unused opioids in the house? That is, besides the extra cost to the patient and/or the insurance company? Isn’t it more convenient than having to call the doctor to get a refill and go back to the pharmacy? Well, no, it isn’t better. Prescribing more opioids than needed opens [...]

6 06, 2017

Patients report worse outcomes with higher opioid dosages – Study

June 6th, 2017|Categories: Opiates, Painkillers|Tags: , , , , |0 Comments

If you’ve been taking opioids for pain and found things getting worse the more you took instead of better, you’re not alone. A large study by researchers at the VA and Kaiser Permanente found that increases in frequency and dosage are associated with worse patient-reported outcomes – more pain and more dysfunction. “One of the things that makes this current study unique is that it’s the first to identify more impairment, and higher pain based on opioid dose, when using question and answer survey instruments,” lead researcher Benjamin Morasco, PhD, told Pain Medicine News (PMN). Most earlier opioid use studies used medical records, which don’t [...]

30 05, 2017

‘Gray Death’ – The Latest Deadly Heroin Mixture

May 30th, 2017|Categories: Heroin|Tags: , , , , |0 Comments

If someone you care about is abusing street-level opioids like heroin, this information could save their life. A new heroin-based mixture of opioids, nicknamed ‘the gray death’ by investigators, is causing record overdoses and deaths across several states, authorities say. Gray death is so unexpectedly powerful that even experienced drug users are overdosing and dying in record numbers. Street dealers often can’t tell their customers what’s in the bag. They get it from the higher-ups, they peddle it, and after people start dying they find out what they’ve been selling that’s killing their customers. Gray death is the latest, and the deadliest yet, in a [...]

25 05, 2017

Experts Weigh In On FDA’s Role Combating Opioid Epidemic

May 25th, 2017|Categories: Fentanyl, Heroin, Legal, Opiates|Tags: , , , , , , , |0 Comments

President Trump's newly appointed FDA Commissioner, Scott Gottlieb, told his first gathering of agency staff last week that "unquestionably, our greatest immediate challenge is the problem of opioid abuse." Gottlieb said the opioid epidemic is "a public health crisis of staggering human and economic proportion" and is a problem that the FDA "cannot solve alone." But the FDA has an important role to play by "giving health care providers the tools to reduce exposure to opioids to only clearly appropriate patients." The new Commissioner, who was previously senior advisor to former FDA commissioner Mark McClellan and was later Deputy Commissioner, acknowledged work already done but [...]

23 05, 2017

ERs and Hospitals Search for Alternatives to Opioids

May 23rd, 2017|Categories: Opiates, Painkillers|Tags: , , , , |0 Comments

A 53-year-old car crash victim, suffering unimaginably intense pain from a thigh so badly shattered that pieces of bone were sticking out, begged doctors at a Baltimore, MD, trauma center recently to not give him opioid painkillers. The patient's surprising refusal to accept the standard treatment for such cases was a simple and powerful message. He was a recovered opioid addict, he explained, and didn't want to risk a relapse. Years earlier, another car crash had led him to a pain clinic that prescribed Percocet "just like candy. I can't lose what I worked for," he said. The doctors listened and came up with an [...]

16 05, 2017

New Study: Medical Marijuana Laws Boost Recreational Cannabis Use and Increase Use Disorders as Well

May 16th, 2017|Categories: Legal, Marijuana|Tags: , , , , , , |0 Comments

A new study by Columbia University Medical Center in New York City has found that every state that has legalized medical marijuana is experiencing increases in recreational use and use disorders. At the same time, the study says, states that have not legalized medical marijuana have declining recreational and disorder statistics. The study, published in JAMA Psychiatry, pulled data from national surveys of drug use among adults ages 18 and over, conducted at three points: In 1991 and 1992, before any medical marijuana laws were enacted In 2001 and 2002, shortly after medical marijuana laws were enacted in a few states In 2012 and 2013, [...]

10 05, 2017

In the Media: Tracking Opioid Article on SecuringIndustry.com

May 10th, 2017|Categories: Media|Tags: , , |0 Comments

Article: Tracking opioid supply chain "not enough" to fight illicit trade by SecuringIndustry.com Diversion of opioid analgesics into the black market is fuelling an addiction epidemic that cannot be solved by the traceability system being developed for the US, says an addiction specialist. A far bigger problem – according to Bryn Wesch of Novus Medical Detox Center – is that companies are knowingly oversupplying the market and not being held to account for their actions, claiming the supply chain is too fragmented and complex to be monitored effectively. Some manufacturers are citing the upcoming serialization and tamper-evidence provisions of the Drug Supply Chain Security Act [...]

9 05, 2017

Researchers discover gout treatment drug prevents symptoms of opioid withdrawal

May 9th, 2017|Categories: Addiction, Medical Drug Detox, Opiates|Tags: |0 Comments

Old drug holds great promise for important new use. Researchers at a Canadian university have discovered that a decades-old drug used primarily to treat gout can reduce or eliminate the debilitating symptoms of opioid withdrawal. So far, the effects of the drug have only been tested in the lab on rodents. But those lab results are so promising that the researchers are working towards clinical trials on humans, a necessary step before the drug can be used in the real world. The drug, called probenecid, also sold under the brand name Probalan, has been around for at least 50 years. It increases uric acid excretion [...]

2 05, 2017

Federal Grants Will Help All 50 States Combat Opioid Epidemic

May 2nd, 2017|Categories: Legal, Opiates|Tags: , , , , |0 Comments

Tom Price, M.D., the Trump administration's new Secretary of the U.S. Department of Health and Human Services (HHS), has announced a $485 million grant to help states and territories combat opioid addiction. The grants, to be made available shortly, will be distributed through the State Targeted Response to the Opioid Crisis Grants, a new program to be administered by the Substance Abuse and Mental Health Services Administration (SAMHSA). The $485 million is the first of two rounds of grants totaling $1 billion, provided under the controversial  21st Century Cures Act. "The funding will be distributed to all 50 states, the District of Columbia, four U.S. [...]